Contract Packaging, Logistics, and Distribution

Interest grows in AI, digitalization, robotics, and sustainability.

The new customized system is designed for fully automated and integrated labeling, orientation, and palletization, and it is expected to streamline the current manual processes, according to the press release.

Third-party contract packaging service providers can help save time and money.

Automation of pharmaceutical packaging saves costs and time, say contract packagers.

Tjoapack has doubled its packaging capacity with the completion of its Netherlands facility expansion.

Thermo Fisher Scientific's solution for cell and gene therapies involves a combination of cold chain logistics, serialization compliance, and distribution

Global supply chain experts examine implications of the DSCSA as well as topical considerations around the EU's FMD in this serialization video series ft. manufacturing, packaging, software, and regulatory experts.

Global supply chain experts examine implications of the DSCSA as well as topical considerations around the EU's FMD in this serialization video series ft. manufacturing, packaging, software, and regulatory experts.

Global supply chain experts examine implications of the DSCSA as well as topical considerations around the EU's FMD in this serialization video series ft. manufacturing, packaging, software, and regulatory experts.

Global supply chain experts examine implications of the DSCSA as well as topical considerations around the EU's FMD in this serialization video series ft. manufacturing, packaging, software, and regulatory experts.

For some manufacturers, the goal was to be fully compliant with the DSCSA, including both serialization and aggregation, from day one.

Manufacturers should consider the benefits and risks of contract packaging for stability studies.

Packaging materials, kit design, and cold-chain handling should be optimized for each study.

Freezers, shipping containers, and tracking systems aid distribution of COVID-19 vaccines.

Conversations with CMOs/CDMOs about capabilities and how they work to reduce complexities in the supply chain should focus on cost efficiency, temperature excursions, and sustainability.

Manufacturers and the US government are investing heavily in traditional and non-traditional forms and materials to ensure supplies of containers and delivery devices for COVID-19 treatments and vaccines.

Previous investments set a foundation for later efficiency improvements.

More sustainable and functional packaging protects temperature-sensitive drugs.

Vein-to-vein programs are focusing on data access and traceability.

Contract packaging and clinical supply service company Sharp invested $21 million to expand its packaging capacity and capabilities in Pennsylvania.

PCI Pharma Services expanded capacity of its commercial packaging site in Illinois.

The company is investing approximately $14 million to expand biologics packaging capabilities and capacity at its biologics manufacturing facility in Bloomington, IN.

The company will complete an expansion of its secondary packaging capabilities at its Ravensburg, Germany site by 2020.

The contract development and manufacturing organization released its first serialized products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.

PCI Pharma Services and CSP Technologies will partner on protective packaging solutions for clinical trials and stability testing.